Osiris gets exclusivity for up to 10 years for Prochymal in Europe and defends patent in Australia!
Now just wait for Swissmedic to approve Prochymal for GvHD.
This news negates Alpha Cardinal accusations that competition would put Osiris on the Brink.
Osiris wins Europe and Australia!
Way to go Stanterds for getting it ALL WRONG: Lu, Yuk-Chien, Suraj, and Erik
Grade of "F" for you.
Now get BACK IN THE LAB AND HONOR THE GRANT THAT IS PAYING YOUR SALARY (TAX PAYER DOLLARS BY THE WAY) AND QUIT WASTING TIME AND EMBARRASSING YOUR INSTITUTION.